Procedure guideline for therapy of thyroid disease with 131Iodine

Journal of Nuclear Medicine

Volumn 43, Issue 6, 2002, Pages 856-861

  Meier, Donald A ^a   Brill, David R ^a   Becker, David V ^a   Clarke, Susan E M ^a   Silberstein, Edward B ^a   Royal, Henry D ^a   Balon, Helena R ^a  

^a NONE   (United States)

Author keywords

131Iodine therapy; Hyperthyroidism; Thyroid cancer; Thyroid disease

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; CARBIMAZOLE; CONTRAST MEDIUM; IODINE; IODINE 131; LIOTHYRONINE; POTASSIUM IODIDE; PROPYLTHIOURACIL; SODIUM IODIDE I 131; THIAMAZOLE; THYROXINE;

GOITER; HUMAN; HYPERTHYROIDISM; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; THYROID CANCER; THYROID DISEASE;

HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; THYROID DISEASES; THYROID NEOPLASMS;

EID: 0036083855     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid
2. Treatment of hyperthyroidism with radioactive iodine
3. Lithium as a potential adjuvant to I-131 therapy of metastatic, well differentiated carcinoma
4. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer
5. MIRD dose estimate report no. 5
6. Lithium as an adjuvant of iodine-131 uptake when treating patients with well-differentiated thyroid carcinoma
7. The changing role of radioiodine in the management of differentiated thyroid cancer
8. Papillary and follicular thyroid carcinoma
9. The need for better methods to determine release criteria for patients administered radioactive material
10. Radioiodine therapy for thyroid cancer
11. Therapeutic controversy. The use of radioactive iodine in patients with papillary and follicular thyroid cancer
12. Radiation dosimetry